Search for Clinical Trial Results

Sponsored By

Inclusion Body Myopathy 2 - 14 Studies Found

Status Study
Active, not recruiting Study Name: An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy
Condition: GNE Myopathy
Date: 2015-01-24
Interventions:
  • Drug: ManNac. At doses of 3,00
Completed Study Name: A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy
Condition:
  • GNE Myopathy
  • Hereditary Inclusion Body My
    Date: 2012-01-17
    Interventions:
    • Drug: Sialic Acid Extended Release (SA-ER)

Completed Study Name: Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)
Condition:
  • Hereditary Inclusion Body Myopathy (HIBM)
  • Date: 2012-07-03
    Interventions: Drug: ManNAc Single dose
Recruiting Study Name: A Natural History Study of Patients With GNE Myopathy
Condition: Hereditary Inclusion Body Myopathy
Date: 2011-08-13
Completed Study Name: Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
Condition: Hereditary Inclusion Body Myopathy
Date: 2005-09-18
Interventions: Drug: Immune Globulin
Completed Study Name: Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)
Condition: Hereditary Inclusion Body Myopathy (HIBM)
Date: 2011-05-20
Interventions:
  • Drug: Sialic Acid Extended Release (SA-ER) Tablets

Active, not recruiting Study Name: Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Condition:
  • Hereditary Inclusion Body Myopathy
  • Distal
    Date: 2015-02-27
    Interventions:
    • Drug: Sialic Acid Tablets Othe
Active, not recruiting Study Name: An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid (ER Tablets + IR Capsules) in Patients With GNE Myopathy
Condition:
  • GNE Myopathy
  • HIBM

Date: 2013-04-10
Interventions: Drug: SA-ER tablets and SA-IR capsules
Completed Study Name: Pharmacokinetic Study on N-acetylneuraminic Acid
Condition:
  • Nonaka Myopathy
  • Hereditary Inclusion Body
    Date: 2010-11-08
    Interventions: Drug: NPC-09 NPC-09 tablet NPC-09 contains 50mg or 100mg N-acetylneuraminic acid (anhydride)
Recruiting Study Name: GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)
Condition:
  • Hereditary Inclusion Body Myopathy
  • GNE My
    Date: 2013-02-04
Next >>>